Literature DB >> 6282506

Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.

K Araki, H Nagashima, T Tsuji.   

Abstract

For detection and characterization of circulating immune complexes (CIC) in various liver diseases, a C1q binding test (C1q BT) was used. While the CIC level was almost normal in HB surface antigen (HBsAg) positive asymptomatic carriers, it was relatively high in patients with liver diseases. The study of the sedimentation rate of CIC in various liver diseases showed two kinds of CIC; one greater than the other. During acute exacerbation of chronic active liver diseases, the CIC level reached its peak 1-5 weeks before and after the peak of sGPT. In acid buffer, CIC in one patient with HBsAg positive severe chronic aggressive hepatitis was dissociated into 5-6 fractions by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The two of these fractions proved to be HBsAg and IgG and another three or four undetermined components. At the acute exacerbation period of this case, the fraction pattern of CIC by SDS-PAGE was similar to each other at any of the four stages and HBsAg always composed one of the antigens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282506      PMCID: PMC1536436     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA).

Authors:  S R Cooperband; R C Davis; K Schmid; J A Mannick
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

3.  Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa.

Authors:  A M Prince; C Trepo
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

4.  Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation.

Authors:  N R Shulman; L F Barker
Journal:  Science       Date:  1969-07-18       Impact factor: 47.728

5.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

6.  Complement fixation on cell surfaces by 19S and 7S antibodies.

Authors:  T Borsos; H J Rapp
Journal:  Science       Date:  1965-10-22       Impact factor: 47.728

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

9.  Association between polyarteritis and Australia antigen.

Authors:  D J Gocke; K Hsu; C Morgan; S Bombardieri; M Lockshin; C L Christian
Journal:  Lancet       Date:  1970-12-05       Impact factor: 79.321

10.  Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

Authors:  H O Sjögren; I Hellström; S C Bansal; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

View more
  2 in total

1.  Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases.

Authors:  J Miyaike; Y Iwasaki; A Takahashi; H Shimomura; H Taniguchi; N Koide; K Matsuura; T Ogura; K Tobe; T Tsuji
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.

Authors:  Kazi Abdus Salam; Richard Y Wang; Teresa Grandinetti; Valeria De Giorgi; Harvey J Alter; Robert D Allison
Journal:  Hepatology       Date:  2018-11-01       Impact factor: 17.425

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.